Is fatty liver a risk marker for heart failure?

Por VanWagner, Lisa B.
Publicado no Obesity (Silver Spring) (2017)

New insights into the link between NAFLD and Atherosclerotic Coronary Heart Disease?

Por VanWagner, Lisa B.
Publicado no J Hepatol (2018)

Physical activity as a treatment of non-alcoholic fatty liver disease: A systematic review

Por Whitsett, Maureen, VanWagner, Lisa B
Publicado no World J Hepatol (2015)

Clinical Liver Disease: Introducing hot topics in hepatology

Por VanWagner, Lisa B., Reau, Nancy
Publicado no Clin Liver Dis (Hoboken) (2018)

The role of insulin-sensitizing agents in the treatment of nonalcoholic steatohepatitis

Por Van Wagner, Lisa B., Rinella, Mary E.
Publicado em 2011

Program-specific Reports: Implications and Impact on Program Behavior

Por VanWagner, Lisa B., Skaro, Anton I.
Publicado em 2013

Evaluating Elevated Bilirubin Levels in Asymptomatic Adults

Por VanWagner, Lisa B., Green, Richard M.
Publicado no JAMA (2015)

Elevated Serum Ferritin

Por VanWagner, Lisa B., Green, Richard M.
Publicado no JAMA (2014)

Survival effects of physical activity on mortality among persons with liver disease()

Por Loprinzi, Paul D., VanWagner, Lisa B.
Publicado no Prev Med Rep (2015)

Extrahepatic Manifestations of Nonalcoholic Fatty Liver Disease

Por VanWagner, Lisa B., Rinella, Mary E.
Publicado no Curr Hepatol Rep (2016)

Lean NAFLD: A not so benign condition?

Por VanWagner, Lisa B., Armstrong, Matthew J.
Publicado no Hepatol Commun (2018)

Diagnostic challenges of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis

Por Cleveland, Erin, Bandy, Andrew, VanWagner, Lisa B.
Publicado no Clin Liver Dis (Hoboken) (2018)

Liraglutide-Induced Autoimmune Hepatitis

Por Kern, Emily, VanWagner, Lisa B., Yang, Guang-Yu, Rinella, Mary E.
Publicado no JAMA Intern Med (2014)

Dapagliflozin-Induced Acute-on-Chronic Liver Injury

Por Levine, Joshua A., Lo, Amy Ann, Wallia, Amisha, Rogers, Melinda, VanWagner, Lisa B.
Publicado no ACG Case Rep J (2016)

Impact of Renal Impairment on Cardiovascular Disease Mortality After Liver Transplantation for Nonalcoholic Steatohepatitis Cirrhosis

Por VanWagner, Lisa B., Lapin, Brittany, Skaro, Anton I., Lloyd-Jones, Donald M., Rinella, Mary E.
Publicado no Liver Int (2015)

Low incidence of acute rejection in hepatitis B virus positive liver transplant recipients and the impact of hepatitis B immunoglobulin

Por Veerappan, Annapoorani, VanWagner, Lisa B., Mathew, James M., Huang, Xuemei, Miller, Joshua, Lapin, Brittany, Levitsky, Josh
Publicado no Hum Immunol (2016)

Hepatocellular carcinoma decreases the chance of successful hepatitis C virus therapy with direct-acting antivirals

Por Prenner, Stacey B., VanWagner, Lisa B., Flamm, Steven L., Salem, Riad, Lewandowski, Robert J., Kulik, Laura
Publicado no J Hepatol (2017)

Gestational Diabetes Mellitus is Strongly Associated with Non-Alcoholic Fatty Liver Disease

Por Ajmera, Veeral H., Gunderson, Erica P., VanWagner, Lisa B., Lewis, Cora E., Carr, John J., Terrault, Norah A.
Publicado no Am J Gastroenterol (2016)

High early cardiovascular mortality following liver transplantation

Por VanWagner, Lisa B., Lapin, Brittany, Levitsky, Josh, Wilkins, John T., Abecassis, Michael M., Skaro, Anton I., Lloyd-Jones, Donald M.
Publicado em 2014

Factors associated with major adverse cardiovascular events after liver transplantation among a national sample

Por VanWagner, Lisa B, Serper, Marina, Kang, Raymond, Levitsky, Josh, Hohmann, Samuel, Abecassis, Michael, Skaro, Anton, Lloyd-Jones, Donald M.
Publicado no Am J Transplant (2016)